Crinetics Pharmaceuticals Cut to Neutral From Overweight by Cantor Fitzgerald
Dow Jones Newswires
Crinetics Pharmaceuticals Cut to Neutral From Overweight by Cantor Fitzgerald
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:CRNX
- Language
- English